106 related articles for article (PubMed ID: 27199208)
1. Real-world surgical outcomes of a gelatin-hemostatic matrix in women requiring a hysterectomy: a matched case-control study.
Obermair H; Janda M; Obermair A
Acta Obstet Gynecol Scand; 2016 Sep; 95(9):1008-14. PubMed ID: 27199208
[TBL] [Abstract][Full Text] [Related]
2. An In Vivo Comparison of Hemostatic Gelatin Matrix Products in a Porcine Spleen Biopsy-punch Model.
Hutchinson RW; Werrlein S; Johns DB; Zhang G; Clymer JW; Kocharian R
Surg Technol Int; 2015 Nov; 27():53-7. PubMed ID: 26680379
[TBL] [Abstract][Full Text] [Related]
3. Safety biocompatibility of gelatin hemostatic matrix (Floseal and Surgiflo) in neurosurgical procedures.
Gazzeri R; Galarza M; Alfier A
Surg Technol Int; 2012 Dec; 22():49-54. PubMed ID: 22915500
[TBL] [Abstract][Full Text] [Related]
4. Real-world economic and clinical outcomes associated with current hemostatic matrix use in spinal surgery.
Danker W; Kelkar SS; Marston XL; Aggarwal J; Johnston SS
J Comp Eff Res; 2022 Dec; 11(17):1231-1240. PubMed ID: 36306241
[TBL] [Abstract][Full Text] [Related]
5. Comparison the efficacy of hemorrhage control of Surgiflo Haemostatic Matrix and absorbable gelatin sponge in posterior lumbar surgery: A randomized controlled study.
Ma L; Dai L; Yang Y; Liu H
Medicine (Baltimore); 2018 Dec; 97(49):e13511. PubMed ID: 30544449
[TBL] [Abstract][Full Text] [Related]
6. Observational evaluation of outcomes and resource utilization from hemostatic matrices in spine surgery.
Price JS; Tackett S; Patel V
J Med Econ; 2015; 18(10):777-86. PubMed ID: 25934148
[TBL] [Abstract][Full Text] [Related]
7. Similar patient outcomes yet different hospital costs between flowable hemostatic agents.
David G; Lim S; Gunnarsson C; Kocharian R; Roy S
J Med Econ; 2015; 18(9):735-45. PubMed ID: 25907200
[TBL] [Abstract][Full Text] [Related]
8. Cost-consequence analysis of two different active flowable hemostatic matrices in spine surgery patients.
Makhija D; Rock M; Ikeme S; Kuntze E; Epstein JD; Nicholson G; Price JS; Patel V
J Med Econ; 2017 Jun; 20(6):606-613. PubMed ID: 28287015
[TBL] [Abstract][Full Text] [Related]
9. Real-world outcomes of hemostatic matrices in cardiac surgery.
Tackett SM; Calcaterra D; Magee G; Lattouf OM
J Cardiothorac Vasc Anesth; 2014 Dec; 28(6):1558-65. PubMed ID: 25245578
[TBL] [Abstract][Full Text] [Related]
10. Intraoperative anaphylaxis secondary to intraosseous gelatin administration.
Luhmann SJ; Sucato DJ; Bacharier L; Ellis A; Woerz C
J Pediatr Orthop; 2013; 33(5):e58-60. PubMed ID: 23752162
[TBL] [Abstract][Full Text] [Related]
11. Efficacy, Security, and Manageability of Gelified Hemostatic Matrix in Bleeding Control during Thoracic and Lumbar Spine Surgery: FloSeal versus Surgiflo.
Landi A; Gregori F; Marotta N; Delfini R
J Neurol Surg A Cent Eur Neurosurg; 2016 Mar; 77(2):139-43. PubMed ID: 26351870
[TBL] [Abstract][Full Text] [Related]
12. A gelatin-thrombin matrix for hemostasis after endoscopic sinus surgery.
Woodworth BA; Chandra RK; LeBenger JD; Ilie B; Schlosser RJ
Am J Otolaryngol; 2009; 30(1):49-53. PubMed ID: 19027513
[TBL] [Abstract][Full Text] [Related]
13. Incidence of thromboembolic events after use of gelatin-thrombin-based hemostatic matrix during intracranial tumor surgery.
Gazzeri R; Galarza M; Conti C; De Bonis C
Neurosurg Rev; 2018 Jan; 41(1):303-310. PubMed ID: 28439721
[TBL] [Abstract][Full Text] [Related]
14. Cost-consequence analysis of different active flowable hemostatic matrices in cardiac surgical procedures.
Makhija D; Rock M; Xiong Y; Epstein JD; Arnold MR; Lattouf OM; Calcaterra D
J Med Econ; 2017 Jun; 20(6):565-573. PubMed ID: 28097913
[TBL] [Abstract][Full Text] [Related]
15. Hemostatic efficacy of two topical adjunctive hemostats in a porcine spleen biopsy punch model of moderate bleeding.
MacDonald MH; Zhang G; Tasse L; Wang D; De Leon H; Kocharian R
J Mater Sci Mater Med; 2021 Sep; 32(10):127. PubMed ID: 34591193
[TBL] [Abstract][Full Text] [Related]
16. Prospective, randomized, controlled clinical trial of a novel matrix hemostatic sealant in children undergoing adenoidectomy.
Mathiasen RA; Cruz RM
Otolaryngol Head Neck Surg; 2004 Nov; 131(5):601-5. PubMed ID: 15523433
[TBL] [Abstract][Full Text] [Related]
17. FLOSEAL Versus SURGIFLO in Lumbar Surgery: Similar Outcomes, Different Costs in a Matched Cohort Analysis.
Ye IB; Thomson AE; Smith RA; Pease TJ; Chowdhury N; Donahue J; Miseo V; Jauregui JJ; Cavanaugh DL; Koh EY; Ludwig SC
World Neurosurg; 2023 Jun; ():. PubMed ID: 37356481
[TBL] [Abstract][Full Text] [Related]
18. Surgiflo
El-Fattah AMA; Ebada HA; Tawfik A
Clin Otolaryngol; 2020 Nov; 45(6):870-876. PubMed ID: 32734638
[TBL] [Abstract][Full Text] [Related]
19. Reducing blood loss at myomectomy with use of a gelatin-thrombin matrix hemostatic sealant.
Raga F; Sanz-Cortes M; Bonilla F; Casañ EM; Bonilla-Musoles F
Fertil Steril; 2009 Jul; 92(1):356-60. PubMed ID: 19423098
[TBL] [Abstract][Full Text] [Related]
20. Gelatin Paste as an Alternative Cost-Effective Hemostatic Agent in Cranial Surgery: Doing More with Less.
Serrato-Avila JL; Navarro-Fernández JO; Hernández-Reséndiz R; Cacho-Díaz B; Reyes-Soto G; Monroy-Sosa A
World Neurosurg; 2019 Feb; 122():224-228. PubMed ID: 30415038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
